enterolactone breast cancer methodological issues contribute conflicting results observational studies pubmed ncbi abstract lignans found plant foods converted intestinal microflora enterolignans structure enterolignans similar estrogens inspired researchers examine potential protective association relation health outcomes numerous epidemiological studies measured concentration enterolignans enterolactone blood urine biomarker lignan exposure studied relation breast cancer risk case-control studies shown decreased breast cancer risk high circulating enterolactone concentrations results demonstrated prospective cohort studies clear purpose review discuss factors contribute contradictory findings obtained epidemiological studies including age distribution enterolactone measurement error heterogeneity breast cancer subtypes genetic factors sources enterolactone precursors contribute inconclusive results conclusion robust evidence health effects lignans enterolactone effort put methodological problems including reducing measurement errors enterolactone estimation identify factors modify effect copyright num elsevier rights reserved 
